These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1766495)

  • 41. Massive hemorrhage due to hemodialysis-associated thrombocytopenia.
    Vicks SL; Gross ML; Schmitt GW
    Am J Nephrol; 1983; 3(1):30-3. PubMed ID: 6601462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet activation and PDGF-AB release during dialysis.
    Donati G; Cianciolo G; D'Addio F; Colì L; La Manna G; Feliciangeli G; Stefoni S
    Int J Artif Organs; 2002 Dec; 25(12):1128-36. PubMed ID: 12518957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.
    Mahiout A; Meinhold H; Kessel M; Schulze H; Baurmeister U
    Artif Organs; 1987 Apr; 11(2):149-54. PubMed ID: 3036050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
    Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
    Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH.
    Renaux JL; Thomas M; Crost T; Loughraieb N; Vantard G
    Kidney Int; 1999 Mar; 55(3):1097-103. PubMed ID: 10027949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinical study on different cellulosic dialysis membranes.
    Falkenhagen D; Bosch T; Brown GS; Schmidt B; Holtz M; Baurmeister U; Gurland H; Klinkmann H
    Nephrol Dial Transplant; 1987; 2(6):537-45. PubMed ID: 3126455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use.
    Heierli C; Markert M; Frei J; Lambert PH; Wauters JP
    Blood Purif; 1986; 4(1-3):82-7. PubMed ID: 3730165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of ticlopidine on coagulation and platelet functions during hemodialysis with cuprophan membranes.
    Grekas D; Syrganis C; Romtsou S; Makris P; Tsakiris DA; Tourkantonis A
    Life Support Syst; 1985; 3 Suppl 1():409-13. PubMed ID: 2959822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
    Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
    Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formation of thrombin-antithrombin III complex using polyamide and hemophan dialyzers.
    Schultze G; Hollmann S; Sinah P
    Int J Artif Organs; 1992 Jun; 15(6):370-3. PubMed ID: 1639530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet depletion, platelet activation and coagulation during treatment with hemodialysis.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Scand J Clin Lab Invest; 2011 May; 71(3):240-7. PubMed ID: 21303224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effect of hemodialysis membranes on human lymphocyte natural killer function.
    Kay NE; Raij L
    Artif Organs; 1987 Apr; 11(2):165-7. PubMed ID: 3496074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo model of hemodialysis membrane biocompatibility.
    Spencer PC; Schmidt B; Samtleben W; Bosch T; Gurland HJ
    Trans Am Soc Artif Intern Organs; 1985; 31():495-8. PubMed ID: 3879781
    [No Abstract]   [Full Text] [Related]  

  • 59. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin is unable to prevent contact activation by three different membranes.
    Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
    Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.